Efectividad y seguridad de tocilizumab en una paciente con orbitopatía de graves Effectiveness and safety of tocilizumab in corticoid refractory Graves' Orbitopathy

1. Perello Carbonell R, Smithson Amat A, Supervia Caparros A, Arenillas Rocha L, Torrente Segarra V, Skaf Peters E. Fiebre y dolor abdominal. Un caso de fiebre mediterranea familiar. An Med Interna. 2004; 21: 590-2. 2. Nicolas Sanchez J, Arostegui Gorospe JI, Encinas Pinol A, Sarrat-Nuevo RM. Fiebre Mediterranea Familiar. Med Clin (Barc). 2010; 134: 660–3. 3. Centola M, Aksentijevich I, Kastner DL. The hereditary periodic fever syndromes: Molecular analysis of a new family of inflammatory diseases. Hum Mol Genet. 1998; 7: 1581–8. 4. Kondi A, Hentgen V, Piram M, Letierce A, Guillaume-Czitrom S, Kone-Paut I. Validation of the new paediatric criteria for the diagnosis of Familial Mediterranean Fever: data from a mixed population of 100 children from the French reference centre for auto-inflammatory disorders. Rheumatology (Oxford) 2010; 49: 2200-3. 5. Buades Reines J, Aguirre Erraste C. Fiebre Mediterranea Familiar. Med Clin (Barc). 2001; 117: 142-6. 6. Fichas tecnicas de Medicamentos. Agencia Espanola de Medicamentos y Productos Sanitarios. Disponible en www.agemed.es 7. Kuijk LM, Govers AM, Frenkel J, Hofhuis WJ. Effective treatment of colchicine resistant familial Mediterranean fever patient with Anakinra. Ann Rheum Dis. 2007; 66: 1545-6.